S 1615

  • New Jersey Senate Bill
  • 2022-2023 Regular Session
  • Introduced in Senate Feb 14, 2022
  • Passed Senate Jun 30, 2023
  • Passed Assembly Jun 30, 2023
  • Signed by Governor Jul 10, 2023

Establishes certain data reporting requirements for prescription drug supply chain; establishes Drug Affordability Council; appropriates $1,500,000.*

Votes


Actions


Jul 10, 2023

Governor of New Jersey

Approved P.L.2023, c.106.

Jun 30, 2023

Senate

Passed Senate (24-11)

Assembly

Received in the Assembly without Reference, 2nd Reading

Assembly

Substituted for A2840 (2R)

Assembly

Passed Assembly (Passed Both Houses) (55-20-1)

Jun 26, 2023

Senate

Senate Amendment (Voice) (Ruiz)

May 11, 2023

Senate

Reported out of Senate Committee with Amendments, 2nd Reading

Mar 14, 2022

Senate

Reported out of Senate Committee, 2nd Reading

Senate

Referred to Senate Budget and Appropriations Committee

Feb 14, 2022

Senate

Introduced in the Senate, Referred to Senate Commerce Committee

Bill Text

Bill Text Versions Format
Introduced Version PDF HTML
Reprint SBA 5/11/23 1R PDF HTML
Reprint Senate 6/26/23 2R PDF HTML

Related Documents

Document Format
Floor Statement Senate 6/26/23 1R
Statement SBA 5/11/23
Statement SCM 3/14/22
Legislative Fiscal Estimate 5/23/23; 1R
Legislative Fiscal Estimate 3/24/22; as introduced
Pamphlet Law Corrected Copy
Advance Law

Sources

Data on Open States is updated periodically throughout the day from the official website of the New Jersey Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.